Teva must face trial over claims it paid kickbacks to promote Copaxone
Teva Pharmaceutical Industries Ltd must face trial in a lawsuit by the federal government accusing it of defrauding Medicare by using kickbacks to boost sales of its multiple sclerosis drug Copaxone.
Source: reuters.com